Trial record 16 of 27 for:    " June 13, 2007":" July 13, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Engaging Care for HIV-Infected Adolescent Females.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2005 by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Information provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
ClinicalTrials.gov Identifier:
NCT00489034
First received: June 19, 2007
Last updated: NA
Last verified: March 2005
History: No changes posted
  Purpose

The proposed multi-site, longitudinal study will examine the correlation of substance use, mental health disorders, and social networks to engagement in care for HIV-infected adolescent females, aged 13 years, 0 months - 23 years, 11 months, and suggest ways to promote adherence and retention in treatment, care, and prevention programs. Qualitative and quantitative data collection methods will be used with index participants and network members.


Condition
HIV Infection

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Official Title: Drug Use and HIV-Infected Female Adolescents' Care Use

Resource links provided by NLM:


Further study details as provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):

Estimated Enrollment: 200
Study Start Date: July 2003
Detailed Description:

The primary outcome examined in the proposed study is engagement in care, operationalized as the number of clinical visits attended. Clinic visits will be monitored on a weekly basis. Secondary outcomes of interest include medication adherence, sexual risk behaviors, and substance use. For the quantitative study, formal psychological testing will be conducted with index adolescent females, and biological specimens will be collected to validate self-reported drug use. CD-4 counts and viral load will be monitored every three months via chart review.

Index adolescents will be interviewed every six months (with phone interviews focused on service utilization at each six month interval midpoint) for eighteen months while network members will be interviewed at baseline and one year.

Qualitative interviews in the Ethnographic Study will be conducted with a small sub-sample of index and identified network participants from each site at least monthly for a period of at least 18 months. Qualitative interviews will be ethnographic in nature and will rely on participants’ life stories and narratives of social experience to supply their content and to guide their progression.

Qualitative Interviews in the Gender Substudy will be conducted with a subsample of index participants. These qualitative interviews will focus on issues of gender related vulnerabilities and will be used to develop a survey to be administered to all index participants from sites participating in this substudy.

  Eligibility

Ages Eligible for Study:   18 Years to 23 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

QUALITATIVE STUDY (1): ETHNOGRAPHIC STUDY ELIGIBILITY

Study Eligibility: In-depth Interviews

• Index Participants

  • Approximately 10 index participants between the ages of 18 years, 0 months and 23 years, 11 months will be recruited for in-depth interviews at the substudy sites.
  • Their selection need not be random; however, they should be participants who are enrolled already in the quantitative study.
  • Index participants who are involved in the ethnographic study are eligible to participate in the gender substudy interviews also, if they wish.

Inclusion/ Exclusion Criteria: Inclusion

  • Age 18 years, 0 months - 23 years, 11 months
  • Enrolled in quantitative study
  • English-speaking

SURVEY

Following initial development supported by in-depth interviews, the survey assessing gender vulnerability will be introduced as an additional instrument to be administered to all index participants in the quantitative study during the 12-month or 18-month quantitative study visit for index participants at New York, Miami, and Chicago, and at the 6-month or 12-month quantitative study visit for index participants at New Orleans.

Study Eligibility: Survey

• Index Participants

Index participants who are between the ages of 18 years, 0 months and 23 years, 11 months and who are enrolled in the quantitative study will be eligible to complete the gender survey. The survey will be introduced at the 12-month or 18-month study visit of the quantitative study in New York, Miami, and Chicago, and at the 6-month or 12-month quantitative study visit for index participants at New Orleans.

Inclusion/ Exclusion Criteria: Inclusion

  • Age 18 years, 0 months - 23 years, 11 months
  • Enrolled in quantitative study
  • English-speaking
  • Female
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00489034

Locations
United States, California
Universtiy of Southern California
Los Angeles, California, United States, 90033
United States, Florida
University of Miami, School of Medicine
Miami, Florida, United States, 33101
United States, Illinois
Stroger Hospital of Cook County
Chicago, Illinois, United States, 60612
United States, Louisiana
Tulane Medical Center
New Orleans, Louisiana, United States, 70112
United States, New York
Montefiore Medical Center
Bronx, New York, United States, 10467
Sponsors and Collaborators
Investigators
Study Director: Lori Perez, Ph.D Westat
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00489034     History of Changes
Other Study ID Numbers: ATN 009, 1RO1DA14706-01
Study First Received: June 19, 2007
Last Updated: June 19, 2007
Health Authority: United States: Federal Government

Keywords provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):
HIV
adolescent females
adherence
clinical care
risk behaviors

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases

ClinicalTrials.gov processed this record on April 22, 2014